Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
Bioventus Inc (NASDAQ: BVS) closed the day trading at $6.38 down -2.45% from the previous closing price of $6.54. In other words, the price has decreased by -$2.45 from its previous closing price. On the day, 0.7 million shares were traded. BVS stock price reached its highest trading level at $6.58 during the session, while it also had its lowest trading level at $6.34.
Ratios:
For a better understanding of BVS, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 22.99 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 21.90. For the most recent quarter (mrq), Quick Ratio is recorded 0.89 and its Current Ratio is at 1.43. In the meantime, Its Debt-to-Equity ratio is 2.40 whereas as Long-Term Debt/Eq ratio is at 2.13.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, JP Morgan on December 17, 2024, Upgraded its rating to Neutral and sets its target price to $13 from $12 previously.
On December 07, 2023, Canaccord Genuity Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $7.
Craig Hallum Upgraded its Hold to Buy on August 09, 2023, whereas the target price for the stock was revised from $4 to $6.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 11 ’25 when Singleton Mark Leonard sold 3,875 shares for $7.57 per share. The transaction valued at 29,334 led to the insider holds 141,088 shares of the business.
D’Adamio Anthony sold 2,958 shares of BVS for $22,392 on Apr 11 ’25. The SVP & General Counsel now owns 131,416 shares after completing the transaction at $7.57 per share. On Apr 11 ’25, another insider, CHURCH KATRINA J, who serves as the SVP & Chief Compliance Officer of the company, sold 1,283 shares for $7.57 each. As a result, the insider received 9,712 and left with 55,557 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BVS now has a Market Capitalization of 423361504 and an Enterprise Value of 804020544. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.92 while its Price-to-Book (P/B) ratio in mrq is 2.85. Its current Enterprise Value per Revenue stands at 1.416 whereas that against EBITDA is 13.672.
Stock Price History:
The Beta on a monthly basis for BVS is 0.87, which has changed by -0.03770739 over the last 52 weeks, in comparison to a change of 0.11241627 over the same period for the S&P500. Over the past 52 weeks, BVS has reached a high of $14.38, while it has fallen to a 52-week low of $5.28. The 50-Day Moving Average of the stock is -23.37%, while the 200-Day Moving Average is calculated to be -36.73%.
Shares Statistics:
Over the past 3-months, BVS traded about 406.46K shares per day on average, while over the past 10 days, BVS traded about 651900 shares per day. A total of 66.23M shares are outstanding, with a floating share count of 44.90M. Insiders hold about 32.33% of the company’s shares, while institutions hold 48.91% stake in the company. Shares short for BVS as of 1745971200 were 972870 with a Short Ratio of 2.39, compared to 1743379200 on 742601. Therefore, it implies a Short% of Shares Outstanding of 972870 and a Short% of Float of 3.8399997999999997.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
